Skinvisible (SKVI) Total Liabilities (2010 - 2026)

Skinvisible has disclosed Total Liabilities across 17 years of filings, most recently posting $10.6 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $10.6 million, up 10.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.6 million (up 10.59% YoY), and the FY2025 annual result was $10.4 million, up 10.75% from the prior year.
• Total Liabilities came in at $10.6 million for Q1 2026 at Skinvisible, up from $10.4 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $10.6 million in Q1 2026 to a low of $5.8 million in Q1 2022.
• The 5-year median for Total Liabilities is $9.4 million (2024), against an average of $8.8 million.
• Across the five-year window, Total Liabilities surged 43.82% in 2023 and climbed 1.22% in 2025, its largest moves.
• Skinvisible's Total Liabilities stood at $6.9 million in 2022, then surged by 33.37% to $9.2 million in 2023, then gained by 2.13% to $9.4 million in 2024, then rose by 10.75% to $10.4 million in 2025, then grew by 2.49% to $10.6 million in 2026.
• The last three Total Liabilities figures came in at $10.6 million (Q1 2026), $10.4 million (Q4 2025), and $10.1 million (Q3 2025), per Business Quant data.